Navigation Links
Lung Cancer Alliance Calls American Cancer Society's Claim of Progress Selective
Date:5/29/2009

WASHINGTON, May 29 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) said that the American Cancer Society's claim of "progress in cancer fight" earlier this week was based on "selective culling of statistics and ignores the dismal truth that we have made very little progress on the most lethal cancers, including lung cancer, which causes one in every two cancer deaths, or in metastatic cancer of any kind."

(Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO)

LCA President & CEO Laurie Fenton Ambrose agreed that progress has been made with certain cancers such as breast, prostate and colon which have widely accepted screening tests for early detection and ACS deserves credit for promulgating information to the public on the importance of these tests.

"But this is not time to be celebrating when half of all cancers still have survival rates of less than 50% and when we are facing a 45% increase in the overall number of new cancer cases by the year 2030," she said, citing a recent report on the upcoming tidal wave in the Journal of Clinical Oncology.

"There could be no stronger wake-up call," she said. "We can't continue to tout selected changes in incidence and mortality rates over a limited number of cancers over a limited period of time. We have to step back and look at the big picture and try to figure out why we have not done better and where we have to go from here."

In 1975 when the so-called War on Cancer was launched, the incidence rate (the number of men and women with cancer for each 100,000 of population) was 400.4. In 2006, the rate was 456.2. The death rate in 1975 was 199.1. In 2006 it was 187.0. The explanation for why the death rate has fallen depends on the type of cancer, levels of respective research funding, behavior modifications, and the deployment and awareness of early detection methods.

For example, breast cancer's five-year survival rate has increased from 75% in 1975 to 89% in 2005, prostate cancer from 67% to 99% and colon cancer from 50% to 65% respectively.

In contrast, lung cancer's five year survival rate is still only 15.6%.

"The toll of lung cancer is now so high that it is taking more lives each year than the next four biggest cancers - colon, breast, pancreas and prostate - combined, and has surpassed every other disease except heart disease as a cause of death," she said.

"There is nothing to celebrate in these figures," she said. "Clearly we have to re-think the war on cancer, especially those most lethal, such as lung cancer."

Lung Cancer Alliance (www.lungcanceralliance.org) is the only national non-profit organization solely dedicated to patient support and advocacy for the lung cancer community. LCA's mission is to lead the movement to reverse decades of stigma and neglect by empowering those with or at risk for the disease, elevating awareness and changing health policy.

    CONTACT:
    Kay Cofrancesco
    kay@lungcanceralliance.org
    202-463-2080


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... Watsonville, California (PRWEB) , ... May 04, 2016 ... ... powerful formulation of foundational nutrients that supports cellular and metabolic health. This synergistic ... and 400 mg free-form curcumin, along with 150 mg of reduced glutathione and ...
(Date:5/4/2016)... ... , ... Natalie Jill is a well respected lifestyle mentor and ... launch of her new book: Natalie Jill’s 7 Day Jump Start: Unprocess Your Diet ... start a new healthy lifestyle featuring simple recipes using MitoXcell’s raw cacao formula. ...
(Date:5/4/2016)... ... May 04, 2016 , ... Bayco Products has announced the ... dual-light flashlights in models NSP-9842XL and NSR-9844XL . , First previewed at ... uses 2 included CR-123 batteries to produce up to 650 lumens in a ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... ankles, and elbows. Engineered with athletes in mind, OMNIFORCE offers high-performance, less ... ineffective circular knitting, common in the industry) produces premium flat-knit construction with ...
(Date:5/4/2016)... KS (PRWEB) , ... May 04, 2016 , ... ... Transtem™ Patient 2016, a powerful cellular therapy software application that helps blood ... treatments to patients. , Since Transtem’s initial launch, Mediware has continued to enhance ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Research and Markets has ... Myeloma Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... Highlights 2016, provides comprehensive insights into Multiple ... Myeloma market valuations and forecast, Multiple Myeloma ...
(Date:5/4/2016)... May 4, 2016 ... the  "Global Acute lymphocytic Leukemia Market and ... their offering.       (Logo: ... Lymphocytic Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Lymphocytic Leukemia epidemiology, ...
(Date:5/3/2016)... acquired a major investment from Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and ... ... ... ... ...
Breaking Medicine Technology: